Market Overview:
The global onychomycosis treatment market reached a value of US$ 2.94 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.12 Billion by 2027, exhibiting at a CAGR of 5.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete’s foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.
Onychomycosis Treatment Market Trends:
The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global onychomycosis treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease type, treatment type, drug class and distribution channel.
Breakup by Disease Type:
- Distal Subungual Onychomycosis
- Proximal Subungual Onychomycosis
- White Superficial Onychomycosis
- Candidal Onychomycosis
- Others
Breakup by Treatment Type:
- Laser Therapy
- Photodynamic Therapy
- Drug Treatment
Breakup by Drug Class:
- Allylamine
- Azole
- Griseofulvin
- Others
Breakup by Distribution Channel:
- Hospitals and Clinics
- Online Stores
- Retail Pharmacies
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Disease Type, Treatment Type, Drug Class, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global onychomycosis treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global onychomycosis treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the drug class?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global onychomycosis treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Onychomycosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Type
6.1 Distal Subungual Onychomycosis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Proximal Subungual Onychomycosis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 White Superficial Onychomycosis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Candidal Onychomycosis
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Laser Therapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Photodynamic Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Drug Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Drug Class
8.1 Allylamine
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Azole
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Griseofulvin
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Online Stores
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cipla Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Dr. Reddy's Laboratories
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Galderma SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline PLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Kaken Pharmaceutical Co. Ltd
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Lumenis Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8 Moberg Pharma AB
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 The OTC Lab B.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2021
Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2021
Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2021
Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2021
Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2021
Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
Table 8: Global: Onychomycosis Treatment Market: Key Players